AzTrials
AzTrials

Cardiac ArrestBASICNCT03926325

Baseline Investigation of Patients With Cardiac Arrest in China

An observational study of Cardiac Arrest, run by Qilu Hospital of Shandong University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

BASIC is a perspective, multicentre and large-scale registry focusing on of patients suffering a cardiac arrest in China. The aims of the study are to establish the monitoring sites covering out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) in urban and rural areas in 7 regions (East China… Read more about this study

Who is it for?
Any age
Conditions the study is for
Cardiac Arrest
How many people
200,000 participants
Where
1 siteChina
Study dates
1 Jul 2019to 31 Dec 2023
How long will I take part?
3 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: consecutive patients with cardiac arrest

Who may be able to join

  • OHCA: Every patient who suffered a cardiac arrest that occurred in any location other than a hospital, and was attended and/or treated by an EMS.
  • IHCA: Every patient who suffered a cardiac arrest in hospital.
  • the representative population-based survey: Every patient who suffered a cardiac arrest in the selected cities or suburbs.

Who cannot join

  • OHCA: 1)The out-of-hospital cardiac arrest patients who were taken to the hospital by their family members; 2) Bystanders suspected cardiac arrest, but the ROSC was achieved without defibrillation or resuscitation by EMS.
  • IHCA: The patient who suffered a cardiac arrest that occurred out-of-hospital and then transferred to the hospital.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012

    Feng Xu, Dr, +86-18560083066, xufengsdu@126.com

    Chang Pan, Dr, +86-18560082290, panchang0517@163.com

    Recruiting

Other trials in China

About this study

BASIC is a perspective, multicentre and large-scale registry focusing on of patients suffering a cardiac arrest in China. The aims of the study are to establish the monitoring sites covering out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) in urban and rural areas in 7 regions (East China, North China, South China, Central China, Northeast China, Southwest China and Northwest China) around China, to collect data from cardiac arrest patients, and to describe basic characteristics, treatments, outcomes, incidences and risk factors of OHCA and IHCA in China.

Conditions
Cardiac Arrest
Medical subject headings
Heart Arrest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of OHCA treated by EMS

    Measured: Latest data inclusion June 30, 2022

  2. incidence of IHCA

    Measured: Latest data inclusion June 30, 2022

  3. survival to hospital discharge or 30d survival of OHCA

    Measured: at hospital discharge, 30days after cardiac arrest occurs

  4. survival to hospital discharge or 30d survival of IHCA

    Measured: at hospital discharge, 30days after cardiac arrest occurs

  5. prevalence of favorable neurological outcome after cardiac arrest according to Cerebral Performance Category (CPC) Scale

    CPC 1 and 2 as a favorable neurological outcome; CPC 1, Good Cerebral Performance; CPC 2, Moderate Cerebral Disability; CPC 3, Severe Cerebral Disability; CPC 4, Coma, vegetative state; CPC 5, Brain death

    Measured: at hospital discharge, 30days after cardiac arrest occurs

Secondary outcomes (4)
  1. survival of OHCA

    Measured: 6 months and 1 year after cardiac arrest occurs

  2. survival of IHCA

    Measured: 6 months and 1 year after cardiac arrest occurs

  3. prevalence of favorable neurological outcome after cardiac arrest according to Cerebral Performance Category (CPC) Scale

    CPC 1 and 2 as a favorable neurological outcome; CPC 1, Good Cerebral Performance; CPC 2, Moderate Cerebral Disability; CPC 3, Severe Cerebral Disability; CPC 4, Coma, vegetative state; CPC 5, Brain death

    Measured: 6 months and 1 year after cardiac arrest occurs

  4. rate of return of spontaneous circulation

    Measured: Latest data inclusion June 30,2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2019
  2. Study start1 Jul 2019
  3. Primary completion30 Jun 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200,000 participants (estimated)
Target duration
3 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT03926325
Sponsor's protocol ID
QLEmer201904
Acronym
BASIC
Status last verified
Oct 2022
First submitted
19 Apr 2019
Last updated
4 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Xie X, Zheng J, Zheng W, Pan C, Ma Y, Zhu Y, Tan H, Han X, Yan S, Zhang G, Li C, Shao F, Wang C, Zhang J, Bian Y, Ma J, Cheng K, Liu R, Sang S, Zhang Y, McNally B, Ong MEH, Lv C, Chen Y, Xu F; BASIC-OHCA Coordinators and Investigators. Efforts to Improve Survival Outcomes of Out-of-Hospital Cardiac Arrest in China: BASIC-OHCA. Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e008856. doi: 10.1161/CIRCOUTCOMES.121.008856. Epub 2022 Dec 12.

    PubMed 36503279

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, run by Qilu Hospital of Shandong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Feng Xu, Dr (+86-18560083066, xufengsdu@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of OHCA treated by EMS (time frame: Latest data inclusion June 30, 2022). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03926325, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in